"Priming" endothelial progenitor cells a new strategy to improve cell based therapeutics

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 6, 2008, Pages 1034-1035

  Gurtner, Geoffrey C ^a   Chang, Edwin ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; STROMAL CELL DERIVED FACTOR 1ALPHA; STROMAL CELL DERIVED FACTOR 1;

ARTERY INTIMA PROLIFERATION; CELL ACTIVATION; EDITORIAL; ENDOTHELIUM CELL; HEART INFARCTION; LIMB ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PULMONARY HYPERTENSION; STEM CELL; STEM CELL EXPANSION; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; ANGIOGENESIS; ANIMAL; CELL ADHESION; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; HUMAN; MESENCHYMAL STEM CELL; METHODOLOGY; NOTE; PHYSIOLOGY; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANIMALS; CELL ADHESION; CHEMOKINE CXCL12; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HUMANS; MESENCHYMAL STEM CELLS; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION; UMBILICAL VEINS;

EID: 44849135836     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.108.163246     Document Type: Editorial

References (21)

1. Gurtner GC, Callaghan MJ, Longaker MT. Progress and potential for regenerative medicine. Annu Rev Med. 2007;58:299-312.
2. Weissman A. Essays Upon Heredity. 1889, Claredon Press: Oxford.
3. Weissman IL, Anderson DJ, Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol. 2001;17:387-403.
4. Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luriá EA, Ruadkow IA. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol. 1974;2(2):83-92.
5. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145-1147.
6. Gearhart J. Cell biology: new potential for human embryonic stem cells. Science. 1998;282:1061-1062.
7. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997:275:964-967.
8. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function, and. cardiovascular risk. N Engl J Med. 2003;348:593-600.
9. Tepper OM, Galiano RD, Capia JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002; 106:2781 2786.
10. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes. 2004;53:195-199.
11. Chen JZ, Zhang FR, Tao QM, Wang XX, Zhu JH. Number and activity of endothelial progenitor cells from peripheral blood in patients with, hypercholesterolaemia. Clin Sci (bond). 2004;107:273-280.
12. Vasa M, Fichtischerer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeier S. Number and migratory activity of circulating endolhe-liai progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:e1-e7.
13. Kondo T, Hayashi M, Takeshita K, Numaguchi Y, Kobayashi K. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vase Biol. 2004; 24:1442-1447.
14. Wang X, Zhu J, Chen J, Shang Y. Effects of nicotine on the number and activity of circulating endothelial progenitor cells. J Clin Pharmacol. 2004;44:881-888.
15. Kalka C, Mlasuda H, Takahashi. T, Kalka-Moll W, Silver M, Kearney M, Li T, J Isner J, Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA. 2000;97:3422-3427.
16. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex. vivo. Nat Med. 2001;7:1035-1040.
17. Takahashi. M, Nakamura T, Toba T, Kajiwara N, Kato H. Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs. Tissue Eng. 2004;10:771-779.
18. Kawamoto A, Gwon HC, Iwaguro H, Yamaguchi JI, Uchida S, Masuda H, Silver M, Ma H, Kearney M, Isne JM, Asahara T. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation. 2001;103:634-637.
19. Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, Shah PK, Willerson JT, Benza L, Berman DS, Gibson CM, Bajamonde A, Rundle AC, Fine J, McCluskey ER. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation. 2003;107:1359-1365.
20. Carmeliet P. VEGF gene therapy: stimulating angiogenesis or angiomagenesis? Nature Medicine. 2000;6:1102-1103.
21. Zemani F, Silvestre JS, Fauvel-Lafeve F, Brael A, Vilar J, Bieche I, Laurendeau I, Galy-Fauroux I, Fischer AM, Boisson-Vidal C. Ex vivo priming of EPC with SDF-I before transplantation could, increase their porangiogenic potential. Arterioscler Thromb Vasc Biol. 2008;28:644-650.